Reimbursement stimulates South Korea's contrast media
This article was originally published in Clinica
Demand for radioactive contrast media in South Korea has been increasing rapidly since the inclusion of CT and MRI scans in the reimbursement system at the end of 1995. South Korea's contrast media market is expected to total around Won 150,000 million ($193 million) by the end of the decade, reports Pharma Koreana.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.